The Antidepressant Effects of Hypoglycaemic Agents: New Insights from an Analysis of the FDA Adverse Event Reporting System (FAERS) Database

被引：0
|
作者：
Carnovale, C. [1 ]
Battini, V. [1 ]
Gringeri, M. [1 ]
Mosini, G. [1 ]
Guarnieri, G. [1 ]
Radice, S. [1 ]
Clementi, E. [1 ]
Manen, R. P. V. [2 ]
机构：
[1] Univ studi Milano, Dept Biomed & Clin Sci, Milan, Italy
[2] Oracle Hlth Sci Global Business Unit, Kattendijke, Netherlands
来源：
DRUG SAFETY | 2022年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P350
引用
收藏
页码：1285 / 1285
页数：1
相关论文
共 50 条
  • [31] Comparing Common Therapies in Polycythemia Vera (PV): A Disproportionality Analysis in the FDA Adverse Event Reporting System (FAERS) Database
    Snopek, Frank
    Seddighzadeh, Ali
    Flynn, Megan
    Cai, Ling-Yu
    Chen, Esther
    Shih, Weichung Joe
    Qin, Albert
    Urbanski, Raymond W.
    [J]. BLOOD, 2023, 142
  • [32] A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
    Zou, Fan
    Zhu, Chengyu
    Lou, Siyu
    Cui, Zhiwei
    Wang, Dan
    Ou, Yingyong
    Wang, Li
    Chen, Junyou
    Lan, Yuanbo
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [33] Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Zhou, Chaozheng
    Peng, Shengkun
    Lin, Anqi
    Jiang, Aimin
    Peng, Yuanxi
    Gu, Tianqi
    Liu, Zaoqu
    Cheng, Quan
    Zhang, Jian
    Luo, Peng
    [J]. ECLINICALMEDICINE, 2023, 59
  • [34] Real-world pharmacovigilance analysis of galsulfase: a study based on the FDA adverse event reporting system (FAERS) database
    Li, Shangze
    Huang, Runcheng
    Meng, Yuanyuan
    Liu, Yijia
    Qian, Jiao
    Zou, Junjie
    Yang, Jun
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Severe hypoglycemia in children treated with nadolol: A case report and FDA adverse event reporting system (FAERS) database analysis
    Bergamaschi, Francesco
    Fumagalli, Mara
    Mannarino, Savina
    Carlucci, Patrizia
    Radice, Sonia
    Gringeri, Michele
    Mosini, Giulia
    Carnovale, Carla
    Battini, Vera
    Fabiano, Valentina
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (04) : 333 - 340
  • [36] Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
    Ma, Zhuo
    Pei, Jie
    Sun, Ximu
    Liu, Lihong
    Lu, Wenchao
    Guo, Qixiang
    Lyu, Jiayou
    Liu, Yuwei
    Zhang, Yuhui
    Zhao, Zhixia
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [37] Time to onset analysis of montelukast associated suicidal ideation using data from FDA adverse event reporting system database (FAERS)
    Viswam, Subeesh Kulangara
    Reddy, Neha
    Yalamanchili, Jahnavi
    Dsouza, Prizvan Lawrence
    Mazhar, Faizan
    Gouri, Nair
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 479 - 479
  • [38] BEVACIZUMAB-ASSOCIATED ESOPHAGEAL PERFORATIONS: A CASE SERIES FROM THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE
    Wichelmann, Thomas Adam
    Weaver, Mandy
    AbdulMujeeb, Sufyan
    Ehnrenpreis, Eli D.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S16 - S16
  • [39] Sarcoidosis associated with pembrolizumab alone or in combination with chemotherapy agents: A pharmacovigilance analysis of the FDA adverse event reporting system (FAERS)
    Pawar, Mansi
    Lukose, Lipin
    Viswam, Subeesh K.
    Salim, Mohammed K. T.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 639 - 639
  • [40] Analysis of tolerance to antidepressant drug treatment in FDA Adverse Event Reporting System
    Carnovale, Carla
    Gentili, Marta
    Vigano, Caterina
    Carnaghi, Giulia
    Beltrami, Marta
    Bosi, Monica
    [J]. PHARMACOLOGICAL RESEARCH, 2019, 141 : 616 - 617
12345